Clinical Trials Browser

Thyroid Neoplasms × Sorafenib × 1 year × Clear all

NCT02185560 2026-04-14

JPMS-DTC

Active not recruiting

Thyroid Neoplasms

NCT01141309 2025-07-22

Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer

Phase 2 Active not recruiting

Thyroid Diseases, Thyroid Neoplasms